Treatment with Ipragliflozin + Metformin well-tolerated in TII patients

A recent RCT set out to determine the safety and tolerability of ipragliflozin in combination with metformin on lowering glucose in patients with type 2 diabetes. The study also looked at the pharmacokinetic (PK) properties of metformin.

Read more

Posted in Type II Drugs